Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 3/20 | 0.36 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.36 |
| ▸ | SLC6A11 | P48066 | 4/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.33 |
| ▸ | KIF11 | P52732 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL169678 | 1.00 | SLC5A2 (0.36) | SLC5A2SLC5A1SLC6A11SLC6A1KIF11 | |
| SCHEMBL169679 | 1.00 | SLC5A2 (0.36) | SLC5A2SLC5A1SLC6A11SLC6A1KIF11 | |
| SCHEMBL132699 | 0.87 | SLC6A11 (0.38) | SLC6A11SLC6A1KIF11HTTLMNA | |
| SCHEMBL135522 | 0.84 | SLC6A11 (0.35) | SLC5A2SLC5A1SLC6A11SLC6A1LMNA | |
| SCHEMBL169481 | 0.78 | EGFR (0.35) | SLC5A2SLC5A1SLC6A11SLC6A1KDM4E | |
| SCHEMBL169480 | 0.78 | EGFR (0.35) | SLC5A2SLC5A1SLC6A11SLC6A1KDM4E | |
| SCHEMBL131200 | 0.78 | — | — | |
| SCHEMBL131201 | 0.78 | — | — | |
| SCHEMBL133759 | 0.75 | SLC6A1 (0.33) | SLC6A11SLC6A1HTTLMNAMAPT | |
| SCHEMBL6277830 | 0.75 | SLC6A1 (0.33) | SLC6A11SLC6A1HTTLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040219565-A1 | Oligonucleotides useful for detecting and analyzing nucleic acids of interest | EXIQON A/S (DK) | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219565-A1 | Oligonucleotides useful for detecting and analyzing nucleic acids of interest | UPF1, DCLRE1B, SNRPA1 | SLC5A2 4038/4885SLC5A1 3162/4885SLC6A11 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.